"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17. 

Experts hope their findings offer valuable insights that one day lead to improved interventions aimed at preserving brain function in patients with Huntington's. 

Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston. 

Bayer’s latest contrast agent is proving its potential in clinical trials as a promising alternative to agents with higher gadolinium content. 

Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.

Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco. 

The American Medical Association this week criticized cuts to physician pay, while Medicare Advantage plans are slated to see a 4.33% boost. 

Its flagship product is the Studycast imaging workflow platform, which CSI billed as “more than a picture archiving and communication system." 

HHS isn’t waiting to see what its incoming secretary does before filling some key leadership positions.